Testicular Cancer clinical trials in Indiana

6 actively recruiting testicular cancer trials at 7 sites across Indiana.

Data from ClinicalTrials.gov · last refreshed 2026-04-20

Phase 3 Recruiting Network

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is removed. When the germ cell tumor has spread outside of the organ in which it dev…

Sponsor: Children's Oncology Group

NCT ID: NCT03067181

Sites in Indiana:

IU Health North Hospital — Carmel, Indiana
Deaconess Clinic Downtown — Evansville, Indiana
Indiana University/Melvin and Bren Simon Cancer Center — Indianapolis, Indiana
Riley Hospital for Children — Indianapolis, Indiana
Ascension Saint Vincent Indianapolis Hospital — Indianapolis, Indiana

View on ClinicalTrials.gov →

Phase 3 Recruiting Network

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy and immunotherapy (chemo-immunotherapy) for patients with High-Risk B-cell Acute Lymphoblastic Leukemia (B-ALL) improves outcomes. Inotuzumab o…

Sponsor: Children's Oncology Group

NCT ID: NCT03959085

Sites in Indiana:

Riley Hospital for Children — Indianapolis, Indiana
Ascension Saint Vincent Indianapolis Hospital — Indianapolis, Indiana

View on ClinicalTrials.gov →

Phase 3 Recruiting Academic/Other

Intrathecal Morphine Versus Intravenous Methadone for Postoperative Analgesia Following Retroperitoneal Lymph Node Dissection.

This randomization study is to compare both intrathecal morphine and intravenous methadone, which are both standard of care, for pain management in patients undergoing retroperitoneal lymph node dissections for primary testicular cancer. I…

Sponsor: Indiana University

NCT ID: NCT06593665

Sites in Indiana:

Indiana Univeristy — Indianapolis, Indiana
Indiana University Hospital — Indianapolis, Indiana

View on ClinicalTrials.gov →

Phase 2 Recruiting NIH

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

This phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patients with rare genitourinary (GU) tumors that has spread from where it first started (primary site) to other places in the…

Sponsor: National Cancer Institute (NCI)

NCT ID: NCT03866382

Sites in Indiana:

Reid Health — Richmond, Indiana

View on ClinicalTrials.gov →

Phase 1 Recruiting Industry

Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

The primary purpose of this study is to determine whether the investigational drug XmAb541 is safe and well tolerated, and to determine an optimal and safe dose(s) for further study. The study will also evaluate the effect of XmAb541 on tu…

Sponsor: Xencor, Inc.

NCT ID: NCT06276491

Sites in Indiana:

Indian University Melvin and Bren Simon Comprehensive Cancer Center — Indianapolis, Indiana

View on ClinicalTrials.gov →

Recruiting Academic/Other

Integrated Cancer Repository for Cancer Research

The iCaRe2 is a multi-institutional resource created and maintained by the Fred \& Pamela Buffett Cancer Center to collect and manage standardized, multi-dimensional, longitudinal data and biospecimens on consented adult cancer patients, h…

Sponsor: University of Nebraska

NCT ID: NCT02012699

Sites in Indiana:

Parkview Research Center — Fort Wayne, Indiana

View on ClinicalTrials.gov →

Medical disclaimer: This page aggregates public ClinicalTrials.gov data. It is not medical advice. Always confirm eligibility and enrollment details with the trial site or your oncologist.

Source: ClinicalTrials.gov API v2 · Last checked: 2026-04-20